ArticleBlood advances2018

Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists.

Christopher T Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.